A Double Blind Trial of Pembrolizumab Plus Enzalutamide vs Placebo Plus Enzalutamide In Patients with Metastatic Castration-Resistant Prostate Cancer (MK3475-641)

A Double Blind Trial of Pembrolizumab Plus Enzalutamide vs Placebo Plus Enzalutamide In Patients with Metastatic Castration-Resistant Prostate Cancer (MK3475-641)

Trial Category:
Genitourinary
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members